Viewing Study NCT00671658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:24 AM
Ignite Modification Date: 2026-05-07 @ 8:40 PM
Study NCT ID: NCT00671658
Status: COMPLETED
Last Update Posted: 2020-12-03
First Post: 2008-04-30
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoma View
None HYPER-CVAD View
None Leukemia View
None Acute Lymphoblastic Leukemia View
None ALL View
None Remission Duration View
None Chemotherapy View
None Asparaginase View
None Cyclophosphamide View
None Cytarabine View
None Dexamethasone View
None Doxorubicin View
None Leukine View
None Methotrexate View
None Rituximab View
None Vincristine View